C&R Research Inc. (KOSDAQ:359090)
South Korea
· Delayed Price · Currency is KRW 823.00
+29.00 (3.65%)
At close: Mar 6, 2026
C&R Research Company Description
C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices.
The company’s therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.
C&R Research Inc.
| Country | South Korea |
| Founded | 1997 |
| Industry | Commercial Physical and Biological Research |
| Employees | 510 |
| CEO | Moontae Yoon |
Contact Details
Address: C&R Building, 412 Seoul South Korea | |
| Phone | 82 2 6251 1500 |
| Website | cnrres.com |
Stock Details
| Ticker Symbol | 359090 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Moontae Yoon | Chief Executive Officer |